Viewing StudyNCT06408584



Ignite Creation Date: 2024-05-11 @ 8:31 AM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06408584
Status: RECRUITING
Last Update Posted: 2024-05-21
First Post: 2024-03-07

Brief Title: Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab
Sponsor: Anhui Provincial Hospital
Organization: Anhui Provincial Hospital

Conditions & Keywords Data

Conditions:
Name
Esophageal Squamous Cell Carcinoma
Keywords:
Name View
Short course hypofractionated radiotherapy View
esophageal squamous cell carcinoma View
tirelesizumab View
Raltitrexed View